Allotment

Chandan Healthcare is launching an IPO through a book-building issue of ₹107.27 crore, comprising a fresh issue of 0.45 crore shares worth ₹70.73 crore and an offer for sale of 0.23 crore shares worth ₹36.54 crore. The proceeds from the fresh issue will go to the company, while the offer for sale proceeds will be received by the selling shareholders.
Issue Details
The price band for the IPO is set at ₹159 per share. Investors can bid for a minimum of 800 shares and in multiples of 800 shares thereafter. For retail investors, the minimum investment is ₹1,27,200 (based on the upper price of ₹159 per share), while High Net Worth Individuals (HNIs) must invest in 2 lots (1,600 shares) totaling ₹2,54,400. The IPO also includes a reservation of up to 2,45,600 shares for employees, offered at a discount of ₹15 per share to the issue price.
Timeline
The IPO opened on February 10, 2025, and closed on February 12, 2025. The allotment was finalized on February 13, 2025, and the shares were subsequently listed on NSE SME on February 17, 2025.
Key Participants
Unistone Capital Pvt. Ltd. is the Book Running Lead Manager, Kfin Technologies Ltd. serves as the Registrar of the Issue, and R.K. Stock Holding Pvt. Ltd. is the Market Maker, ensuring liquidity and smooth trading post-listing.
₹1590%
Open
HIgh - Low
Previous Close
Total Traded Value
52 Weeks High
52 Weeks Low
Updates On
IPO. Open
IPO. Close
IPO. Price
IPO Market price
| IPO Date | 17 Feb |
| IPO Listing Date | 17 Feb |
| IPO Face Value | ₹10 per share |
| IPO Price Range | ₹159.00 |
| IPO Issue Size | 67,52,000 shares |
| IPO Sale Type | Fresh Capital & OFS |
| Employee Discount | ₹15.00 |
| IPO Issue Type | Bookbuilding IPO |
| IPO Listing | NSE SME Platform |
| Share Holding Pre Issue | 2,00,00,000 shares |
| IPO Open Date | 10 Feb |
| IPO Close Date | 12 Feb |
| IPO Allotment (Tentative) | 13 Feb |
| Refunds | 14 Feb |
| Credit to Demat Account | 14 Feb |
| IPO Listing Date | 17 Feb |
| Category | Offer |
|---|---|
| QIB Shares Offered | 30,82,400 Shares |
| NII (HNI) Shares Offered | 9,25,600 Shares |
| Retail Shares Offered | 21,59,200 Shares |
Investors can bid for a minimum of 800 shares and in multiples of 800 shares thereafter
| Application | Lots | Share | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 800 | ₹1,27,200 |
| Retail (Max) | 1 | 800 | ₹1,27,200 |
| S-HNI (Min) | 2 | 1,600 | ₹2,54,400 |
| S-HNI (Max) | - | - | - |
| B-HNI (Min) | - | - | - |
Incorporated in September 2003, Chandan Healthcare Limited operates diagnostic centres across North India, providing comprehensive pathology and radiology testing services. The company also runs a subsidiary, Chandan Pharmacy Limited, which operates medical stores offering a wide range of pharmaceutical products.
Operations and Network
As of December 31, 2024, Chandan Healthcare manages one flagship laboratory, seven central laboratories, and twenty-six satellite centres, supported by over 300 collection centres across more than 23 cities in Uttar Pradesh and 19 cities in Uttarakhand. The company offers 1,496 diagnostic tests, including 481 routine pathology tests, 1,015 specialised pathology tests, and 545 radiology tests such as X-rays, ultrasonography, CT, MRI, and specialised CT scans. Its radiology facilities are equipped with 11 CT scanners and 4 MRI machines.
Workforce and Services
The company employs 15 radiologists, 23 pathologists, and over 161 other qualified professionals to provide diagnostic and wellness services. Its offerings include routine and specialized pathology tests, radiology tests, preventive and wellness services, and home collection services.
Competitive Strengths
Chandan Healthcare’s key strengths include a strong geographic presence in Uttarakhand, covering 39 tier-two cities and towns, an integrated diagnostics model combining pathology, radiology, and medical consultations, a track record of profitability, and a dedicated management team with significant industry experience.
| Assets | 170.06 | 128.86 | 97.83 |
| Total Income | 167.99 | 177.96 | 137.03 |
| Profit After Tax | 17.42 | 16.36 | 3.59 |
| EBITDA | - | - | - |
| NET Worth | - | 41.09 | 27.3 |
| Reserves and Surplus | 34.31 | 21.16 | 7.37 |
| Total Borrowing | 51.92 | 42.01 | 21.36 |
| ROE | 47.50% |
| ROCE | 35.20% |
| Debt/Equity | 1.02 |
| RoNW | 39.54% |
| PAT Margin | 9.26% |
| EBITDA Margin | - |
| Price to Book Value | 7.73 |
IPO Objects of the Issue
| S.No. | Objects of the ipo Resources Detail | IPO Amount |
|---|---|---|
| 1 | Funding capital expenditure requirements for the purchase of equipment/machineries | - |
| 2 | To meet out the expenses of Working Capital Requirement | - |
| 3 | To meet out the General Corporate Purposes; | 16.72 |
| 4 | Offer for Sale (OFS) | - |
Chandan Healthcare Ltd. Address
Biotech Park, Sector G,
Jankipuram,
Kursi Road,
Lucknow, Uttar Pradesh, 226021
+91 8429024430
secretarial@chandan.co.in
https://www.chandandiagnostic.com/
IPO Registrar
Kfin Technologies Ltd.
04067162222, 04079611000
chl.ipo@kfintech.com
https://ipostatus.kfintech.com/